Janssen Diagnostics, Inc. is a global Johnson & Johnson Company based in Raritan, NJ, United States and Beerse, Belgium (Janssen Diagnostics, BVBA) committed to personalizing healthcare worldwide. The Janssen Diagnostics team is dedicated to improving patients’ lives, one by one, by making true personalized care the cornerstone of our future healthcare system. Our goal is to think beyond drug treatment and grow as a true solution provider. The Janssen legacy of excellence in Infectious Diseases, Oncology, Neuroscience, Cardiovascular Diseases and Immunology will continue to drive innovation in the fields of Diagnostics Solutions and Health Information Technology, enabling us to reach our goal: to develop care solutions that cater to each individual’s needs.
Janssen Diagnostics' mission is to bring practical, innovative information tools that assist healthcare professionals in making informed treatment decisions and personalize the care of patients with complex conditions like HIV and other infectious diseases. The company provides resistance interpretation through the use of its vircoTYPE™ HIV-1 product as well as education and facilitating access to resistance interpretation worldwide. It has an electronic health record (EHR) business in the U.S., and an R&D program in personalized medicine and companion diagnostics across a number of infectious diseases.
Janssen Diagnostics, Inc. is committed to supporting the HIV/AIDS community and continues to work as a partner with healthcare professionals in this therapeutic area as it did as Virco Lab, Inc. for more than 15 years. Janssen Diagnostics, Inc. continues listen to the challenges and opportunities that clinicians and other healthcare professionals have encountered in treating HIV/AIDS in an effort to consistently enhance the products and services the company provides to better meet the needs of the HIV/AIDS community.
In December 2009, Virco (now Janssen Diagnostics, Inc.) acquired LAB TRACKER™ HIV, a customizable electronic health record (EHR) from Ground Zero Software. The product has been completely redesigned using insights from healthcare professionals immersed in HIV care to meet today and tomorrow’s clinical needs, and to ensure it meets Meaningful Use requirements. AVIGA™ and AVIGA REPORTER™ are natural extensions of the Janssen Diagnostics, Inc. overall product line and commitment to its core mission and values: to support HIV healthcare professionals with integrated information from multiple sources to effectively manage their patients living with HIV/AIDS.
EHRs offer several advantages for general patient management and are particularly useful for complex diseases, such as HIV, which often have a multitude of test results, analyses, and co-morbidities. The acquisition of LAB TRACKER™ HIV is a natural extension of our overall product line and lends to the Janssen Diagnostics, Inc. commitment to save and improve patients’ lives, through the integration and delivery of differentiating diagnostic and health IT solutions into world-class personalized disease management.
With the acquisition of LAB TRACKER™ HIV, our vision is to further assist HIV clinicians in optimizing treatment decisions for their patients by providing an efficient solution for organizing, analyzing, and evaluating healthcare information from multiple sources in a single convenient and easy to use location. We aspire to develop new products and services in other therapeutic areas by leveraging our experience in affordably analyzing and evaluating patient data that makes optimizing medical solutions timely and actionable.
No. While AVIGA™ maintains many of the core functions and most desirable features that LAB TRACKER™ HIV users valued most, it has been totally redesigned to meet current standards for electronic health records. It includes a more powerful querying and reporting function designed to address the specific needs and challenges of the HIV/AIDS and Infectious Disease communities.
Yes. AVIGA™ is also completely suitable as a general purpose EHR for use in the ambulatory care setting; yet it retains functionalities uniquely required by healthcare professionals involved in HIV/AIDS care.
AVIGA™ is designed to meet the Stage 1 Meaningful Use requirements under the Health Information Technology for Economic and Clinical Health (HITECH) Act. Janssen Diagnostics, Inc. has built AVIGA™ to meet each of the specific Stage 1 meaningful use requirements.
AVIGA™ is fully Stage 1 certified as an EHR for use in ambulatory care settings by the Drummond Group*, one of the Office of the National Coordinator-Authorized Testing and Certification Body (ONC-ATCB) providers.
*This Complete EHR is 2011/2012 compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of the U.S. Department of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. Certification Information: Janssen Diagnostics, Inc., 05/17/13, AVIGA™ 2.0, 05172012-4394-6. Clinical Quality Measures Certified: NQF001, NQF0002, NQF0004, NQF0013, NQF0018, NQF0024, NQF0027, NQF0028,NQF0031, NQF0032, NQF0033, NQF0034, NQF0036, NQF0038, NQF0041, NQF0043, NQF0047, NQF0052, NQF0055, NQF0056, NQF0059, F0061, NQF0062, NQF0064, NQF0067, NQF0068, NQF0070, NQF0073, NQF0074, NQF0075, NQF0084, NQF0086, NQF0088, NQF0089, NQF0105, NQF0385, NQF0387, NQF0389, NQF0421, NQF0575. The additional software that AVIGA™ 2.0 relied upon to demonstrate compliance includes: popHealth and MIRTH Connect.
AVIGA™ and AVIGA REPORTER™ provide security controls required for HIPAA compliance. If you have specific questions about HIPAA compliance please contact Customer Support for detailed information.
As new requirements for reporting become available, Janssen Diagnostics, Inc. will update the HIV reports in AVIGA™ and AVIGA REPORTER™..
Yes. We provide several individualized training options to meet the needs of your site. Please contact Customer Support for details.
As part of the initial site configuration process, your existing data will be evaluated, and a plan created to transfer your current system to AVIGA™ or AVIGA REPORTER™. Every situation is different, so please contact Customer Support with any questions you may have.
Yes. We have conversion utilities available to help with the migration of your CAREWare™ database to AVIGA™ or AVIGA REPORTER™. Please contact Customer Support for further details. CAREWare™ is a trademark of Jeff Murray's Programming Shop, Inc. and is not affiliated with, associated with, or a sponsor of the AVIGA™ or AVIGA REPORTER™ software.
For the most up-to-date and accurate product pricing, please contact your Janssen Diagnostics, Inc. Sales Representative. To have a Sales Representative contact you, please call 888-224-4230, and then press 3 for Product Sales.
Our toll-free phone line and email support are available to help answer your questions. To reach support by phone, dial 888-224-4230, and then press 2 for Customer Support. You can also email your support questions to AVIGAehr.Support@its.jnj.com
DISCLAIMER: THE INFORMATION CONTAINED IN THIS WEB SITE IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND REPRESENTS NO STATEMENT, PROMISE OR GUARANTEE BY JANSSEN DIAGNOSTICS, INC. CONCERNING RECEIPT OR PAYMENT OF GOVERNMENT INCENTIVES. JANSSEN DIAGNOSTICS, INC. STRONGLY URGES THAT YOU CONSULT WITH YOUR COUNSEL FOR ADVICE ON INCENTIVE ELIGIBILITY.
On February 2nd, 2012, Virco Lab, Inc.
changed its legal name to Janssen Diagnostics, Inc.
Our website is in the process of being updated to
reflect these name changes.